Exclusive: Demis Hassabis on AGI, curing diseases with AI

2026-05-27 · Source: The Rundown AI · Field: Technology & Digital — Artificial Intelligence & Machine Learning, Emerging Technologies & Innovation, Robotics & Autonomous Systems · Depth: Fundamental Awareness, extended

Summary

Google DeepMind CEO Demis Hassabis projects Artificial General Intelligence (AGI) by 2030, plus or minus a year, noting increased confidence despite remaining challenges in world physics understanding, memory, consistency, and continual learning. He also states that AI-driven drug discovery timelines have "hardened," with a focus on oncology and immunology, aiming to compress the drug design process from years to months. Hassabis envisions post-AGI AI assisting in understanding the nature of reality and philosophical questions about humanity. Separately, Nvidia CEO Jensen Huang advises against seeking "AI-proof" subjects, emphasizing that human qualities like creativity, judgment, and emotional connection will become more valuable. A Stanford study, analyzing 4 million job applications from 2018-2022, revealed significant racial bias in AI hiring tools, with Black and Asian applicants disproportionately screened out, a problem exacerbated by shared AI models across employers. The brief also highlights a guide for automating marketing reports using Claude Cowork and updates on AI tools like ElevenLabs Music v2 and OpenRouter's \$113M funding.

Key takeaway

For AI leaders and strategists planning long-term roadmaps, Demis Hassabis's AGI projection for 2030 and hardened drug discovery timelines signal an accelerating AI landscape. You should prioritize investments in foundational AI research addressing current limitations like memory and continual learning, while also developing strategies to integrate AI ethically. Be mindful of potential biases in shared AI infrastructure, as demonstrated by the Stanford hiring study, and focus on cultivating uniquely human skills within your workforce.

Key insights

AGI is projected for 2030, with AI poised to revolutionize drug discovery and redefine valuable human skills.

Principles

• AGI development requires breakthroughs in memory and continual learning.
• Human creativity and judgment gain value in an AI-augmented world.
• AI systems can embed and propagate biases across applications.

Method

Automate weekly marketing reports by creating distinct Claude Cowork skills for data input, draft generation, and final report publishing, iteratively refining skills based on feedback.

In practice

• Use shared AI chats for collaborative planning.
• Evaluate AI agents rigorously before deployment.
• Explore AI for automating routine reporting tasks.

Topics

• Artificial General Intelligence
• AI Drug Discovery
• AI Ethics
• AI Bias
• AI Agent Evaluation
• Workforce Transformation

Best for: CTO, VP of Engineering/Data, Executive, AI Scientist, Director of AI/ML, General Interest

Related on AIssential

• The Arrival of AGI with Shane Legg (co-founder of DeepMind) — AGI is rapidly approaching, necessitating urgent societal and ethical preparedness for its transformative impact.
• An Industry Benchmark for Data Fairness: Sony’s Alice Xiang — Ethically sourced, diverse datasets are crucial for effectively measuring and mitigating bias in AI models.
• You Are Being Told Contradictory Things About AI — Contradictory narratives dominate AI's future, spanning job displacement, AGI paths, and the necessity of recursive self-improvement.
• AI Weekly Issue #477: Jensen Huang says we've achieved AGI. The benchmarks say 0.37%. — Current AI excels at pattern-matching but struggles with novel, adaptive problem-solving, defining its present utility.
• 45 - Samuel Albanie on DeepMind's AGI Safety Approach — A technical AGI safety agenda relies on assumptions about AI development and proposes iterative risk mitigation strategies.
• AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. — AI-driven drug candidate generation creates a bottleneck in molecular characterization, which 10x Science addresses with an AI-powered mass spectrometry platform.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by The Rundown AI.